Couldn’t be more happier to reconnect with my forever mentor and big brother @md_SsAhmad, and the future super star fellow @MFerranteDO @UCincyIM @MCWcardiology

Great seeing old and new trainees presenting their work and even better having a mini reunion @RefaatMostafaMD @MFerranteDO @AlhasanFaysal

We’re incredibly proud of our outstanding PGY3, @D_E_McDuffie, for presenting his work on applying implementation science to enhance adherence to spontaneous breathing trials in our medical ICU! Way to go David! @CincyIM @accpchest #CHEST2024

#GCOS2024 #JACCCardioOnc SimPub: #SGLT2i administration was associated with a significantly decreased risk of developing cancer therapy-related cardiac dysfunction in patients with #T2DM and cancer. https://t.co/n4M08SAkUz #GCOS24 #CardioOnc #Diabetes #T2D @AmmarWB

🔵 TTR amyloid cardiomyopathy: Literature review & red-flag symptom clusters for each cardiology specialty @ESC_Journals #cardioEd #Cardiology #Amyloidosis

#ARNI in #HF with ESRD + dialysis: ⬆️LVEF ➕⬇️☠️ with no risk of hypotension ➕ hyperkalaemia. 👉MA: https://t.co/fVmaXJFbra @AmrAbdin10 @EJHFEiC @GiuseppeGalati_ @HanCardiomd @JanBiegus #EJHF

The game just changed in cardiology! 🫀 Coronary CT #CCTA can now assess coronary microvascular dysfunction – a huge leap forward in diagnosing and treating microvascular disease. 🌟 This could reshape how we approach #CMD 🔥Just published @JACCJournals

Check out this excellent article by @CardioBusiness about our new #ASEGuideline, "Recommendations for Multimodality Imaging of Patients With Left Ventricular Assist Devices and Temporary Mechanical Support!"

Had an incredible time at my first American Society of Nuclear Cardiology conference presenting a case series highlighting the various arrhythmias that cardiac sarcoidosis can present with. Nuclear imaging has proven 🔑 to early identification of infiltrative CM. #ASNC24

Grateful for the opportunity to present a very interesting case on cardiac sarcoidosis at the American Society of Nuclear Cardiology conference!! @MyASNC #ASNC2024 @UCincyIM @uccardiology @PourriahiMD

Nothing to ‘SCOFF’ at! New research out of #ESCCongress suggests fasting prior to cath lab procedures requiring conscious sedation may not be needed. Read more: https://t.co/JKiz6lvan9

Female gender was removed from CHADS-VASc score in new ESC guidelines for management of AF. Rationale : female gender is a risk modifier rather than risk factor for stroke. Now we have a CHADS-VA score.

Exciting news🫀🤩

@UCincyIM

Journal Club Noon Report with one of our favorite future cardiologists @Nrathi21 discussing REDUCE-AMI 🫀

In the VALOR-HCM placebo-controlled trial of #mavacamten for symptomatic obstructive #cvHCM hypertrophic cardiomyopathy, mavacamten improved mitral valve SAM and regurgitation. https://t.co/4U6AwzvceK #JACCIMG @PaulCremerMD @DesaiMilindY @jeffreygeske

The ARTESIA trial showed that anticoagulation reduces adverse events compared with aspirin among patients with subclinical #AFib. Read updates to the trial on treatment differences according to CHA2DS2-VASc: https://t.co/2tKL321etp #Stroke

FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1

Our new paper in @NEJM examines the widespread acquisitions of medical practices by UnitedHealth, Humana, Cigna, and other insurers—what’s driving this trend and what are its implications for patients and clinicians? 1/x

🚨Exciting News! #JSCAI is accepted for PubMed Central Indexing!🎉 Read @AlexandraLansky's editorial: ➡️ https://t.co/R70gqqHc5O 📢This significant milestone boosts our authors' visibility, citation rates, and recognition by making all articles more accessible to researchers